☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
phenylketonuria
BioMarin Reports FDA's Hold on P-I/II Phearless Trial of BMN 307 in Adults with PKU
September 6, 2021
BioMarin Receives the US FDA's Approval Allowing Maximum Dose of 60mg with Palynziq (pegvaliase-pqpz) for PKU
October 8, 2020
BioMarin's Palynziq (pegvaliase injection) Receives European Commission's MAA Approval for Phenylketonuria
May 7, 2019
BioMarin's Palynziq (pegvaliase-pqpz) Receives FDA Approval for Phenylketonuria (PKU) in Adults
May 24, 2018
Load more...
Back to Home
Modal title
×
Modal body text goes here.